XML 52 R40.htm IDEA: XBRL DOCUMENT
v3.23.1

INVESTMENTS – RELATED PARTIES (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2023
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract] |
Schedule of investment |
Schedule of investment |  |  |  |  |  |  |  |  |  |  |  |
|  | Interest |  |  |  | March 31, |  |  | December 31, |
|  | rate |  | Due Date |  | 2023 |  |  | 2022 |
Investment in promissory note of Ault & Company |  | 8% |  | December 31, 2023 |  | $ | 2,500,000 |  |  | $ | 2,500,000 |
Accrued interest receivable, Ault & Company |  |  |  |  |  |  | 418,000 |  |  |  | 368,000 |
Total investment in promissory note, related party |  |  |  |  |  | $ | 2,918,000 |  |  | $ | 2,868,000 |
Summary of interest income, related party, recorded within interest and other income on the condensed consolidated statement of operations:
|  | For the Three Months Ended |
|  | March 31, |
|  | 2023 |  |  | 2022 |
Interest income, related party |  | $ | 50,000 |  |  | $ | 50,000 |
Investment in Common Stock and Options, Related Parties
|  | March 31, |  |  | December 31, |
|  | 2023 |  |  | 2022 |
Investment in common stock of Alzamend |  | $ | 4,856,000 |  |  | $ | 6,449,000 |
Schedule of investment in warrants and common stock |
Schedule of investment in warrants and common stock |  |  |  |
|  | Investment in common stock of Alzamend |
Balance at January 1, 2023 |  | $ | 6,449,000 |
Investment in common stock of Alzamend |  |  | 5,000 |
Unrealized loss in common stock of Alzamend |  |  | (1,598,000 | )
Balance at March 31, 2023 |  | $ | 4,856,000 |
Schedule of investment of common stock |
Schedule of investment of common stock |  |  |  |  |  |  |  |  |  |  |  |
|  | Shares of |  |  | Per Share |  |  | Investment in |
|  | Common Stock |  |  | Price |  |  | Common Stock |
Balance at January 1, 2023 |  |  | 11,415,000 |  |  | $ | 0.56 |  |  | $ | 6,449,000 |
Open market purchases after initial public offering |  |  | 10,000 |  |  | $ | 0.50 |  |  |  | 5,000 |
Unrealized loss in common stock of Alzamend |  |  | - |  |  | $ | - |  |  |  | (1,598,000 | )
Balance at March 31, 2023 |  |  | 11,425,000 |  |  | $ | 0.43 |  |  | $ | 4,856,000 |

X
- References No definition available. + Details
Name: | ault_InvestmentHoldingsScheduleOfInvestmentsOneTableTextBlock
Namespace Prefix: | ault_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ault_ScheduleOfInvestmentsInAlzamendCommonStockAndWarrantsTableTextBlock
Namespace Prefix: | ault_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ault_SummaryInvestmentHoldingsOneTextBlock
Namespace Prefix: | ault_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration